How should I start viloxazine (Viibryd) therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Start Viibryd (Vilazodone)

Start Viibryd at 10 mg once daily with food for 7 days, then increase to 20 mg once daily with food, with the option to further increase to 40 mg once daily after a minimum of 7 additional days. 1

Critical Pre-Initiation Screening

Before prescribing Viibryd, you must screen for:

  • Personal or family history of bipolar disorder, mania, or hypomania - this is mandatory per FDA labeling to avoid precipitating manic episodes 1
  • Current or recent (within 14 days) use of MAOIs - absolute contraindication due to serotonin syndrome risk 1

Standard Titration Protocol

The FDA-approved titration schedule is straightforward 1:

Week 1:

  • 10 mg once daily with food

Week 2 onward:

  • 20 mg once daily with food
  • This is the minimum target therapeutic dose

Week 3+ (if needed):

  • May increase to 40 mg once daily with food
  • Wait minimum 7 days between dose increases
  • Target range is 20-40 mg daily

Critical Administration Requirements

Always take with food - this is non-negotiable. Viibryd's bioavailability is significantly affected by food intake, and taking it on an empty stomach reduces effectiveness 1, 2. Either a light meal or high-fat meal is acceptable 2.

Dose Adjustments for Drug Interactions

With strong CYP3A4 inhibitors (itraconazole, clarithromycin, voriconazole):

  • Do not exceed 20 mg once daily
  • Resume original dose when inhibitor discontinued 1

With strong CYP3A4 inducers (carbamazepine, phenytoin, rifampin) used >14 days:

  • Consider doubling the dose up to maximum 80 mg once daily over 1-2 weeks
  • Taper back to original dose over 1-2 weeks when inducer discontinued 1

MAOI Washout Requirements

  • 14-day washout required both before starting Viibryd after stopping an MAOI and before starting an MAOI after stopping Viibryd 1
  • This includes linezolid and IV methylene blue

Common Pitfalls to Avoid

  1. Don't skip the food requirement - patients often forget this critical detail, leading to suboptimal response
  2. Don't rush titration - the 7-day intervals exist for tolerability reasons
  3. Don't miss bipolar screening - antidepressants can trigger manic episodes in undiagnosed bipolar disorder
  4. Don't abruptly discontinue - when stopping, taper from 40 mg to 20 mg for 4 days, then 10 mg for 3 days; from 20 mg, taper to 10 mg for 7 days 1

Expected Adverse Effects

The most common side effects (≥5% incidence) are diarrhea, nausea, vomiting, and insomnia 1. These are typically mild to moderate and often improve with continued treatment 2. Monitor closely for emergence of suicidal thoughts, particularly in young adults, as this carries a black box warning 1.

Note on Medication Confusion

Be aware that the evidence provided includes information about viloxazine (used for ADHD), which is a completely different medication from vilazodone (Viibryd, used for depression). The question asks about Viibryd (vilazodone), so all dosing recommendations above are specific to the antidepressant vilazodone, not the ADHD medication viloxazine 3.

References

Research

Vilazodone: a novel antidepressant.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2012

Related Questions

How should Qelbree (viloxazine) be initiated and managed in patients with motor or vocal tics, including dosing, monitoring, and discontinuation criteria?
Is Qelbree (viloxazine) an effective treatment for attention-deficit/hyperactivity disorder (ADHD)?
What are the most common adverse effects of viloxazine?
What are the differences between Strattera (atomoxetine) and Qelbree (viloxazine) regarding mechanism of action, dosing, side‑effect profile, and monitoring requirements?
Does Qelbree (viloxazine) cause eye twitching?
I took DayQuil (acetaminophen, dextromethorphan, phenylephrine), Zyrtec (cetirizine), and Pepcid (famotidine) this morning and now have mild dyspnea; what should I do?
Why is Juven (therapeutic nutritional powder) used in patients with acute or chronic wounds or at risk for muscle breakdown?
How should a gum ulcer be treated?
How should a newborn with an arterial pH of 7.13 and a normal venous blood gas be evaluated and managed?
In a 30‑year‑old Black male (6′5″, 320 lb) with persistent ANA positivity (speckled pattern), markedly elevated anti‑RNP antibodies, mildly elevated CK, proximal muscle weakness of shoulders, hips, and thighs, normal EMG, G6PD deficiency, hypertension treated with amlodipine, and weight loss therapy with a GLP‑1 agonist, what is the most likely diagnosis, its prognosis, and does the myopathy represent an inflammatory (dermatomyositis/polymyositis) or necrotizing autoimmune myositis?
What are the typical symptoms of mast cell–related disease and the recommended management strategies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.